Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3410743
Max Phase: Preclinical
Molecular Formula: C18H18O7
Molecular Weight: 346.34
Molecule Type: Small molecule
Associated Items:
ID: ALA3410743
Max Phase: Preclinical
Molecular Formula: C18H18O7
Molecular Weight: 346.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(C(=O)COC(=O)c2cc(OC)ccc2O)c(OC)c1
Standard InChI: InChI=1S/C18H18O7/c1-22-11-5-7-15(19)14(8-11)18(21)25-10-16(20)13-6-4-12(23-2)9-17(13)24-3/h4-9,19H,10H2,1-3H3
Standard InChI Key: YQCZSNWKMXTVPF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 346.34 | Molecular Weight (Monoisotopic): 346.1053 | AlogP: 2.46 | #Rotatable Bonds: 7 |
Polar Surface Area: 91.29 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.13 | CX Basic pKa: | CX LogP: 3.08 | CX LogD: 3.08 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.61 | Np Likeness Score: -0.29 |
1. Khedkar SA, Sun X, Rigby AC, Feinberg MW.. (2015) Discovery of small molecule inhibitors to Krüppel-like factor 10 (KLF10): implications for modulation of T regulatory cell differentiation., 58 (3): [PMID:25581017] [10.1021/jm5018187] |
2. (2017) Use of small molecule inhibitors to klf10 for modulation of t regulatory cells and cancer immunotherapy, |
Source(2):